Morgan Stanley Downgrades Qiagen NV (QGEN) to Equalweight

January 6, 2025 2:23 AM EST Send to a Friend
Morgan Stanley analyst Aisyah Noor downgraded Qiagen NV (NYSE: QGEN) from Overweight to Equalweight with a price target of $48.00 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login